- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?- 10-Q/A Quarterly report
- 31.1 Certificate of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31.2 Certificate of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 32.1 Certification by the Principal Executive Officer Pursuant to 18 U.s.c. 1350 As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 32.2 Certification by the Principal Executive Officer Pursuant to 18 U.s.c. 1350 As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Tannya L. Irizarry, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q/A of GeneThera, Inc. for the quarterly period ended March 31, 2020, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Quarterly Report on Form 10-Q/A fairly presents in all material respects the financial condition and results of operations of GeneThera, Inc.
By: /s/ Tannya L Irizarry | |
Name: Tannya L Irizarry |
Title: Chief Financial Officer (Interim) (Principal Financial/Accounting Officer)
Date: September 10, 2020